跳至主要内容
临床试验/NCT05429216
NCT05429216尚未招募不适用

Modified Cap-assisted Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection for Small Rectal Neuroendocrine Tumors Less Than 1 cm: a Muticenter Randomized Noninferiority Trial

Nanfang Hospital, Southern Medical University0 个研究点目标入组 102 人开始时间: 2022年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
102
主要终点
histological complete resection

研究概览

简要总结

In previous single center study, both modified cap-assisted endoscopic mucosal resection (mEMR-C) and endoscopic submucosal dissection (ESD) were reported to be effective for the treatment of small rectal neuroendocrine tumors (NETs) and mEMR-C was inferior to ESD for the treatment of small rectal NETs (≤10 mm), as it has shorter operation times and lower hospitalization costs. However, a multicenter randomized controlled trial is needed to prove the universality and generality of these findings.

详细描述

Investigators aimed to conduct a muticenter randomized controlled trial to compare mEMR-C with ESD for the treatment of small rectal neuroendocrine tumors (NETs) in six tertiary hospitals in China.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age from 18 to 75 years;
  • •With a high suspicion or evidence of rectal NET assessed using EUS or colonoscopy;
  • •With tumor size ≤10 mm assessed by colonoscopy;
  • •Plan to receive mEMR-C or ESD treatment and provide written informed consent;

排除标准

  • •Unable to tolerate ESD or MEMR-C as assessed by the research team of each center;
  • •Complicated with serious diseases such as malignant tumor, which may lead to shorter life expectancy, the research team considers that it is not suitable for inclusion in the study after comprehensive evaluation;
  • •Rectal NET with lymph node metastasis or distant metastasis;
  • •Received resection of rectal neuroendocrine tumor by other surgical procedures;
  • •Multiple rectal neuroendocrine tumors;
  • •Vulnerable groups such as pregnant women or patients with mental disorders;
  • •Poor compliance, unable to cooperate with treatment.

研究组 & 干预措施

mEMR-C group

Experimental

In mEMR-C group, enrolled patients will receive modified EMR-C without submucosal injection.

干预措施: mEMR-C procedure (Procedure)

ESD group

Active Comparator

In ESD group, enrolled patients will receive the standard treatment modality of ESD to remove the rectal NET

干预措施: ESD procedure (Procedure)

结局指标

主要结局

histological complete resection

时间窗: within 14 days after procedure

complete single-piece (en bloc) resection of the targeted lesion with horizontal and vertical free margins.

次要结局

  • hospitalization cost(within 14 days after procedure)
  • en bloc resection(intraoperative)
  • success rate of operation(intraoperative)
  • complications(within 14 days after procedure)
  • operation time(intraoperative)
  • histopathologic grade(within 14 days after procedure)
  • length of stay(within 14 days after procedure)
  • operation cost(within 14 days after procedure)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Endoscopic Resection for Small Rectal Neuroendocrine... | 临床试验